Administered by individual state BCBS organizations under the BCBS Association umbrella. Coverage varies state-to-state more than most carriers.
Type 2 diabetes coverage
Generally covered for T2D. Typical copay $25–$100/mo with PA.
Weight management coverage
Highly variable by state. Some state BCBS plans cover Wegovy/Zepbound; others exclude. Check specific plan documents.
CV indication coverage
Coverage of Wegovy under March 2024 CV indication expanding. Varies by state plan.
OSA indication coverage
Zepbound has been FDA-approved for OSA since December 2024. Coverage for that use varies by state plan; ask about prior authorization.
Prior authorization (typical)
BMI thresholds (≥30 or ≥27 with comorbidity); documented lifestyle modification; comorbidity documentation.
How to verify
Call member services on your card and ask: (1) Is [Wegovy/Zepbound/Ozempic/Mounjaro] on my formulary? (2) What tier? (3) PA criteria? (4) Expected copay? Document the date, rep's name, and any reference number.
Cash-pay alternative
If insurance is unworkable, see our price index. NexLife, our editor's pick, charges $95 a month for compounded semaglutide or $115 for compounded tirzepatide on a 12-month plan ($109 and $129 month to month; nexlife.us, read November 6, 2026), the same price at every dose. It is not the lowest price we track: Mondae lists lower standing rates, and Eden Health a lower semaglutide rate. Compounded versions are not FDA-approved.